<DOC>
	<DOCNO>NCT02159898</DOCNO>
	<brief_summary>This prospective , single blind , randomize study EndoMAXX EVT Fully Covered Esophageal Stent Valve treatment malignant stricture low esophagus . The purpose study evaluate improvement dysphagia due esophageal stricture EndoMAXX EVT Fully Covered Esophageal Stent Valve ( investigational device ) compare EndoMAXX Fully Covered Esophageal Stent ( reference device ) .</brief_summary>
	<brief_title>EndoMAXX EVT Compared EndoMAXX</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Esophageal Stenosis</mesh_term>
	<criteria>1 . Patient 18 year age old 2 . Patient ( legal representative ) able understand provide sign informed consent 3 . Patient malignant stricture distal esophagus gastric cardia require stent placement across gastroesophageal junction . 1 . Patient unwilling unable comply followup schedule 2 . Patient contraindicate endoscopic procedure reason 3 . Patient present esophagorespiratory fistula 4 . Patient previously undergone esophageal stenting esophagectomy 5 . Female patient pregnant , breastfeeding , premenopausal use effective method contraception 6 . Patient 's esophageal tumor length exceeds treat single stent ( maximum lesion length 9.5cm ) 7 . Removal stent schedule occur within six month 8 . Patient trouble swallow experience regurgitation reason relate his/her esophageal cancer 9 . Any factor identify Investigator would disqualify prospective patient participation study include limited coagulative disorder anesthetic risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Dysphagia</keyword>
	<keyword>Regurgitation</keyword>
</DOC>